Education
About Us
Working with TipRanks
Follow Us
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171
Total Valuation
CARsgen Therapeutics Holdings Ltd. has a market cap or net worth of HK$8.47B. The enterprise value is HK$3.87B.
Market CapHK$8.47B
Enterprise ValueHK$3.87B
Share Statistics
CARsgen Therapeutics Holdings Ltd. has 572,546,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding572,546,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CARsgen Therapeutics Holdings Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-1.61M
Employee Count465
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of CARsgen Therapeutics Holdings Ltd. is ―. CARsgen Therapeutics Holdings Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio286.21
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, CARsgen Therapeutics Holdings Ltd. had revenue of 0.00 and earned -747.79M in profits. Earnings per share was -1.34.
Revenue0.00
Gross Profit0.00
Operating Income-767.65M
Pretax Income-747.39M
Net Income-747.79M
EBITDA-717.64M
Earnings Per Share (EPS)-1.34
Cash Flow
In the last 12 months, operating cash flow was -412.66M and capital expenditures -5.02M, giving a free cash flow of -417.53M billion.
Operating Cash Flow-412.66M
Free Cash Flow-417.53M
Free Cash Flow per Share-0.73
Dividends & Yields
CARsgen Therapeutics Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.54
52-Week Price Change194.56%
50-Day Moving Average13.34
200-Day Moving Average7.72
Relative Strength Index (RSI)59.63
Average Volume (3m)3.56M
Important Dates
CARsgen Therapeutics Holdings Ltd. upcoming earnings date is Aug 26, 2025, TBA Not Confirmed.
Last Earnings DateMar 18, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
CARsgen Therapeutics Holdings Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, CARsgen Therapeutics Holdings Ltd. has paid 407.00K in taxes.
Income Tax407.00K
Effective Tax Rate―
Enterprise Valuation
CARsgen Therapeutics Holdings Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
CARsgen Therapeutics Holdings Ltd. has HK$1.65B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -HK$1.44B billion.
Cash & Marketable SecuritiesHK$1.65B
Total Debt¥0.00
Net Cash-HK$1.44B
Net Cash Per Share-HK$2.51
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for CARsgen Therapeutics Holdings Ltd. is HK$8.96, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetHK$8.96
Price Target Upside-40.19% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-4.33%